Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses
- 1 December 2000
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (4) , 407-414
- https://doi.org/10.1016/s0924-8579(00)00226-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparative Pharmacodynamics of Gatifloxacin and Ciprofloxacin in an In Vitro Dynamic Model: Prediction of Equiefficient Doses and the Breakpoints of the Area under the Curve/MIC RatioAntimicrobial Agents and Chemotherapy, 2000
- Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic modelJournal of Antimicrobial Chemotherapy, 1999
- Bactericidal Activity of Grepafloxacin Against Respiratory PathogensDrugs, 1999
- A New Approach to In Vitro Comparisons of Antibiotics in Dynamic Models: Equivalent Area under the Curve/MIC Breakpoints and Equiefficient Doses of Trovafloxacin and Ciprofloxacin against Bacteria of Similar SusceptibilitiesAntimicrobial Agents and Chemotherapy, 1998
- In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogensInternational Journal of Antimicrobial Agents, 1998
- In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinoloneJournal of Antimicrobial Chemotherapy, 1998
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolatesJournal of Antimicrobial Chemotherapy, 1997
- Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocciJournal of Antimicrobial Chemotherapy, 1996
- In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international studyJournal of Antimicrobial Chemotherapy, 1994